Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May;172(3):499-502.
doi: 10.1007/s11060-025-04941-1. Epub 2025 Feb 3.

Innovation and technology in neurosurgery oncology

Affiliations
Editorial

Innovation and technology in neurosurgery oncology

Isabelle M Germano et al. J Neurooncol. 2025 May.
No abstract available

Keywords: AANS/CNS Section on Tumors; Innovation; Neurosurgery; Technology.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Parney IF, Warnick RE, Lang FF, Rutka JT, Kalkanis S, Glick R, Rosenblum M, Germano IM The AANS/CNS section on tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumors. J Neurosurg. 26:1–7, 2024 PMID: 38277647.
    1. Armocida D, Bianconi A, Zancana G et al (2024) DTI fiber-tracking parameters adjacent to gliomas: the role of tract irregularity value in operative planning, resection, and outcome. J Neurooncol. https://doi.org/10.1007/s11060-024-04848-3 - DOI - PMC
    1. Asfaw ZK, Young T, Brown C et al (2024) Charting the success of neuronavigation in brain tumor surgery: from inception to adoption and evolution. J Neurooncol 170:1–10. https://doi.org/10.1007/s11060-024-04778-0 - DOI
    1. Mirzayeva L, Uçar M, Kaymaz AM et al (2024) Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience. J Neurooncol 168:249–257. https://doi.org/10.1007/s11060-024-04660-z - DOI - PMC
    1. da Silva EB Jr, Ramina R, Filho N (2024) Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations. J Neurooncol 168:555–562. https://doi.org/10.1007/s11060-024-04698-z - DOI

Publication types

LinkOut - more resources